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Abstract
Background: Like mammalian MAP kinases, the mating-specific Fus3 MAPK of yeast accumulates
in the nuclei of stimulated cells. Because Fus3 does not appear to be subjected to active nucleo-
cytoplasmic transport, it is not clear how its activation by mating pheromone effects the observed
change in its localization. One possibility is that the activation of Fus3 changes its affinity for nuclear
and cytoplasmic tethers.
Results: Dig1, Dig2, and Ste12 are nuclear proteins that interact with Fus3. We found that the
pheromone-induced nuclear accumulation of a Fus3-GFP reporter is reduced in cells lacking Dig1
or Dig2, whereas Fus3T180AY182A-GFP localization was unaffected by the absence of these proteins.
This suggests that Dig1 and Dig2 contribute to the retention of phosphorylated Fus3 in the nucleus.
Moreover, overexpression of Ste12 caused the hyper-accumulation of Fus3-GFP (but not
Fus3T180AY182A-GFP) in the nuclei of pheromone-treated cells, suggesting that Ste12 also plays a role
in the nuclear retention of phosphorylated Fus3, either by directly interacting with it or by
transcribing genes whose protein products are Fus3 tethers. We have previously reported that
overexpression of the Msg5 phosphatase inhibits the nuclear localization of Fus3. Here we show
that this effect depends on the phosphatase activity of Msg5, and provide evidence that both nuclear
and cytoplasmic Msg5 can affect the localization of Fus3.
Conclusion:  Our data are consistent with a model in which the pheromone-induced
phosphorylation of Fus3 increases its affinity for nuclear tethers, which contributes to its nuclear
accumulation and is antagonized by Msg5.
Background
Mitogen activated protein kinases (MAPKs) respond to a
wide array of external signals, and are presumed to be
present in all eukaryotes. Cellular proliferation, differenti-
ation, and stress responses are all regulated by MAPKs [1-
4]. The well characterized MAPKs function as part of a sig-
naling module in which a MAPK kinase kinase (MEKK)
phosphorylates and thereby activates a MAPK kinase
(MEK), which then phosphorylates and activates the
MAPK. Upon activation, MAPKs phosphorylate targets in
the nucleus, in the cytoplasm, and at the cell cortex [5,6].
Because MAPKs affect targets throughout the cell, their
localization is a critical aspect of signal regulation [7-9]. In
fact, mislocalization of mammalian ERK MAPKs has been
associated with altered signaling [10-13]. Moreover, the
duration of ERK nuclear localization has been reported to
be very important in determining the outcome of ERK
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activation: proliferation vs. differentiation [14-17].
Immunofluorescence and GFP-tagging experiments have
demonstrated that pathway stimulation causes some
MAPKs to translocate from the cytoplasm to the nucleus
[18-20]. Although nuclear accumulation of MAPKs has
been studied in model systems, the mechanisms that reg-
ulate this phenomenon are not fully understood.
A priori, the nuclear localization of MAPKs can be regu-
lated in two ways: 1) regulated import or export across the
nuclear membrane; 2) release from cytoplasmic tethers
(anchoring proteins) and/or sequestration by nuclear
tethers. Thus far, there are four examples of MAPKs that
are subjected to active transport. In mammals, Erk2 inter-
acts directly with the nuclear pore complex and undergoes
Ran-dependent nuclear import [21-23], whereas Erk3 and
Erk5 are actively exported from the nucleus by the CRM1
exportin [24,25]. In budding yeast, the Hog1 MAPK
undergoes both Ran- and Nmd5-dependent nuclear
import, as well as Crm1-dependent nuclear export [26]. A
number of reports also suggest that tethers influence the
localization of mammalian MAPKs. MEK is thought to be
a cytoplasmic tether for ERK1/2, for example [27]. When
ERK is activated, it releases from MEK, allowing ERK to
localize to the nucleus. PEA-15, hSef, the MKP-3 dual-spe-
cific phosphatase, and the tyrosine phosphatases HePTP
and PTP-SL have also been reported to be cytoplasmic
tethers for ERKs, and β-arrestin is thought to anchor ERK
to endosomal vesicles [28-34]. As yet, DUSP5 is the only
protein reported to tether ERKs in the nucleus [35]. In the
budding yeast S.cerevisiae, the Ptp2 phosphatase and the
Msn2, Msn4, and Hot1 transcription factors act as nuclear
tethers for the Hog1 MAPK, whereas the Ptp3 phosphatase
and the Pbs2 MEK tether Hog1 in the cytoplasm [36-38].
Also in budding yeast, Spa2 retains the Mpk1 MAPK at
sites of polarized growth [39]. Finally, the Atf1 transcrip-
tion factor of S.pombe  has been shown to regulate the
nuclear localization of the Spc1/Sty1 MAPK [40].
To better understand the mechanisms controlling MAPK
localization, we are using the mating reaction of S.cerevi-
siae as a model signaling system. When haploid yeast cells
of opposite mating type are mixed, they undergo a com-
plex mating reaction leading to the formation of zygotes.
Each mating type constitutively secretes a peptide mating
pheromone that triggers cells of the opposite type to arrest
in the G1 phase of the cell cycle, form mating projections
(shmoos), and induce mating-specific genes in prepara-
tion for cell and nuclear fusion. The signal to mate is
transmitted across the plasma membrane by a seven trans-
membrane domain receptor and its associated heterot-
rimeric G protein. Upon release from Gα (Gpa1), the Gβγ
dimer binds to the Ste5 scaffolding protein and stimulates
a Pak kinase. These proteins, in turn, are required for acti-
vation of the MAP kinase cascade. The MAP kinase mod-
ule consists of Ste11 (the MEKK), Ste7 (the MEK), and
Fus3 (the MAPK). Upon activation by Ste7 on the Ste5
scaffold, the Fus3 MAPK accumulates at its sites of action
[41-43]. In the nucleus, Fus3 phosphorylates the Ste12
mating-specific transcription factor [44,45], its two nega-
tive regulators, Dig1 and Dig2 [44,46], and a regulator of
cell division, Far1 [44,45,47]. At the cortex, Fus3 is
thought to phosphorylate Bni1 [48] and Gβ [49].
In proliferating cells, Fus3 is found in both the cytoplasm
and the nucleus, with a slightly greater concentration of
Fus3 in the nucleus [50,51]. Upon pheromone stimula-
tion, the relative proportion of Fus3 in the nucleus
increases. To quantify this pheromone-induced nuclear
accumulation of Fus3, we developed an assay that meas-
ures the relative amount of Fus3 in each compartment
[52]. Digital images of cells expressing a Fus3-GFP
reporter were used to determine the ratio of nuclear to
cytoplasmic fluorescence (RNCF). Using this assay, we
confirmed that pheromone induces a measurable accu-
mulation of Fus3 in the nucleus, and found that this
increase in nuclear Fus3 correlates with the responsive-
ness of cells to pheromone. Cells that are resistant to phe-
romone-induced cell cycle arrest have lower RNCF values;
cells that are hypersensitive to pheromone arrest have
higher RNCF values. Moreover, the relative amount of
Fus3 in the nucleus decreases as cells adapt to pheromone
stimulation and re-enter the mitotic cycle. These results
demonstrate that, although the changes in Fus3 localiza-
tion during the induction and downregulation of the phe-
romone response are small (RNCF values typically range
from 1.6 to 2.0), they are of great consequence to the cell.
It is therefore of interest to determine what regulates the
partitioning of Fus3 between the cytoplasm and the
nucleus.
Using fluorescence recovery after photobleaching (FRAP)
and fluorescence loss in photobleaching (FLIP) analyses,
van Drogen and co-workers found no evidence that the
rate of Fus3 transport either into or out of the nucleus is
regulated by pheromone [51]. Rather, they concluded that
Fus3 rapidly shuttles between the nucleus and cytoplasm
by passive diffusion. If the rate of Fus3 transport across the
nuclear membrane is not regulated by pheromone, then
what causes the accumulation of Fus3 in the nuclei of phe-
romone-treated cells? One possibility is that the activation
of Fus3 alters its affinity for cytoplasmic and nuclear teth-
ering proteins. Consistent with this, Fus3 dissociates from
the Ste5 scaffolding protein in the cytoplasm when it is
phosphorylated by Ste7 [53]. Combining this mechanism
with an increased tendency to bind tethers in the nucleus
could account for the observed signal-induced change in
Fus3 localization.BMC Cell Biology 2007, 8:44 http://www.biomedcentral.com/1471-2121/8/44
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Here we report that three proteins known to interact with
Fus3 in the nucleus (Dig1, Dig2, and Ste12) contribute to
its pheromone-induced redistribution. Our data suggest
that Dig1 and Dig2 are nuclear tethers for Fus3, and that
Ste12 influences Fus3 localization either by directly inter-
acting with it, or by transcribing genes whose protein
products are Fus3 tethers. We also provide evidence that
the phosphorylation state of Fus3 is a key determinant of
its localization, and that the Msg5 phosphatase regulates
Fus3 localization by dephosphorylating it in both the
cytoplasm and in the nucleus. This work supports the idea
that the activation of MAPKs changes their affinity for
anchoring proteins in the cytoplasm and the nucleus,
thereby effecting their signal-induced redistribution.
Results
Dig1 and Dig2 are required for the normal accumulation of 
Fus3 in the nuclei of pheromone-treated cells
Dig1 and Dig2 are nuclear proteins that are known to
interact with both the inactive and active forms of Fus3,
with results from pull-down, two-hybrid, and peptide
array binding experiments suggesting that these interac-
tions are direct [46,54]. They negatively regulate the phe-
romone pathway by binding non-overlapping regions of
Ste12 [55,56], a transcription factor essential for the
expression of mating-specific genes [57-59]. To determine
whether either Dig1 or Dig2 affects the nuclear localiza-
tion of Fus3, we measured the cytoplasmic and nuclear
distribution of Fus3-GFP in wild-type, dig1Δ, and dig2Δ
cells. The distribution of the reporter was not significantly
different in the three strains during vegetative growth (1.7
± 0.17 vs. 1.6 ± 0.19 for dig1Δ vs. wild type, ρ = 0.33; 1.6
± 0.13 vs. 1.6 ± 0.19 for dig2Δ vs. wild type, ρ = 0.40; com-
pare the histograms in Fig. 1). In response to pheromone
treatment, however, the wild-type cells exhibited a signif-
icantly higher concentration of Fus3 in the nucleus as
compared to the mutant cells (1.8 ± 0.12 vs. 2.2 ± 0.14 for
dig1Δ vs. wild type, ρ < 0.0001; 1.9 ± 0.16 vs. 2.2 ± 0.14
for dig2Δ vs. wild type, ρ < 0.0001; compare the histo-
grams in Fig. 1). These data suggest that Dig1 and Dig2
contribute to the nuclear accumulation of Fus3 during the
mating response, but either do not affect the localization
of Fus3 in vegetative cells, or are functionally redundant
in this regard.
Because the effect of dig1Δ and dig2Δ on Fus3-GFP locali-
zation is only detectable after pheromone treatment, and
because pheromone treatment induces the phosphoryla-
tion/activation of Fus3, we wondered whether Dig1 and
Dig2 specifically affect the localization of the phosphor-
ylated form of Fus3. In stimulated cells, the pheromone-
responsive MEK, Ste7, phosphorylates Fus3 on two resi-
dues, T180 and Y182 [60]. To determine the effect of Fus3
phosphorylation on its putative nuclear tethering by Dig1
and Dig2, we used a mutant form of the Fus3 reporter that
cannot be phosphorylated by Ste7, Fus3T180AY182A-GFP
[52]. The mutant reporter localized normally in vegetative
wild type cells, but was defective in pheromone-induced
nuclear accumulation (2.0 ± 0.14 vs. 2.2 ± 0.14 for
Fus3T180AY182A-GFP vs. Fus3-GFP, ρ < 0.0001). Signifi-
cantly, dig1Δ and dig2Δ had no measurable effect on the
localization of the Fus3T180AY182A-GFP reporter (Table 1 -
see additional file 1 for RNCF calculations). The insensi-
tivity of Fus3T180AY182A-GFP localization to deletion of
DIG1 and DIG2 suggests that Dig1 and Dig2 primarily
tether the phosphorylated form of Fus3.
Ste12 overexpression confers hyper-accumulation of Fus3 
in the nuclei of pheromone-treated cells
The Ste12 transcription factor is required for the induction
of many mating-specific genes [57-59]. It localizes to the
nucleus [61] and, based on two-hybrid and biochemical
data, is known to directly interact with Fus3 [45,62].
Therefore, like Dig1 and Dig2, Ste12 might be a nuclear
tether for Fus3. To examine this possibility, we asked
whether overexpression of Ste12 affects the nuclear accu-
mulation of Fus3. We did not test the effect of ste12Δ on
Fus3 localization because Ste12 is essential for normal
activation of the pheromone pathway. A plasmid contain-
ing STE12 under the control of a galactose-inducible pro-
moter was transformed into wild type cells carrying the
Fus3-GFP reporter. Galactose-induced overexpression of
Ste12 did not affect Fus3-GFP localization in vegetative
cells (Fig. 2). However, when Ste12 overexpression was
induced concomitant with the addition of pheromone,
the pheromone-stimulated RNCF was significantly greater
than in the control cells (2.1 ± 0.19 vs. 1.9 ± 0.25 for Ste12
overexpression vs. wild type, ρ = 0.0025; see the 4 hour
time point in Fig. 2). Thus, excess Ste12 causes hyper-
accumulation of Fus3-GFP in the nuclei of pheromone-
treated but not untreated cells. To determine whether this
effect depends on the phosphorylation of Fus3, we
repeated the experiment in cells expressing the
Fus3T180AY182A-GFP reporter. As shown in Figure 2, overex-
pression of Ste12 had no effect on Fus3T180AY182A-GFP
localization (1.9 ± 0.17 vs. 1.9 ± 0.25 for Ste12 overex-
pression vs. wild type, ρ = 0.74; see the 4 hour time point
in Fig. 2), consistent with the idea that Ste12 augments the
nuclear tethering of activated Fus3 (see Additional file 2
for further details).
Msg5 affects the nuclear accumulation of Fus3 by 
dephosphorylating it in both the cytoplasm and the 
nucleus
Msg5 is a pheromone-inducible, dual-specific phos-
phatase known to dephosphorylate and thereby inactivate
Fus3 [63]. We have previously shown that overexpression
of Msg5 lowers the amount of Fus3 found in the nucleus
of vegetative cells [52]. In stimulated cells, excess Msg5
completely blocks the pheromone-induced nuclear accu-BMC Cell Biology 2007, 8:44 http://www.biomedcentral.com/1471-2121/8/44
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Dig1 and Dig2 are required for the pheromone-induced nuclear accumulation of Fus3 Figure 1
Dig1 and Dig2 are required for the pheromone-induced nuclear accumulation of Fus3. Strains of the indicated genotype were 
transformed with Fus3-GFP and grown to mid-log phase. The cultures were then split and grown with or without the addition of 12 nM 
pheromone. Images were acquired from the treated and untreated cells three hours later. The RNCF values were determined as 
described in the Materials and Methods, and their distributions represented in histograms. The number of cells (y axis) is plotted as a 
function of the RNCF values (x axis). Mean RNCF values are indicated ± s.d. In each panel, the untreated and treated cultures are repre-
sented by the left and right histograms, respectively. Arrows indicate the mean RNCF value for each culture. Representative micrographs 
from which the quantitative data were derived are shown beneath each histogram. (A)Wild type cells; (B) dig1Δ cells; (C)dig2Δ cells.BMC Cell Biology 2007, 8:44 http://www.biomedcentral.com/1471-2121/8/44
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Ste12 overexpression causes hyper-accumulation of Fus3 in the nuclei of pheromone-treated cells Figure 2
Ste12 overexpression causes hyper-accumulation of Fus3 in the nuclei of pheromone-treated cells. Wild type cells were 
transformed with either the Fus3-GFP reporter or the Fus3T180AY182A-GFP reporter, and either the GAL1-STE12 plasmid or an empty vec-
tor. Strains were grown to mid-log phase in sucrose medium and galactose was added to a concentration of 2% two hours before phe-
romone treatment (GAL1 promoter on). The cultures were then split and grown with or without the addition of 12 nM pheromone. 
Images were acquired from the untreated and treated cultures in 2 hour intervals. The mean RNCF ± s.d. values were determined as 
described in the Materials and Methods, and are represented in histograms as follows: wild type cells expressing Fus3-GFP–untreated 
(white bars) and treated (dark gray bars); wild type cells expressing Fus3-GFP and overexpressing Ste12–untreated (light gray bars) and 
treated (black bars); wild type cells expressing Fus3T180AY182A-GFP and overexpressing Ste12–untreated (stippled bars) and treated 
(hatched bars). Asterisks indicate statistically significant differences between strains with ρ = 0.003. See additional file 2 for images repre-
sentative of each time point sampled for Figure 2.
Table 1: RNCF and ρ values
-+   a ρ value b ρ value c
control (Fus3-GFP) 1.6 ± 0.19 2.2 ± 0.14 n/a n/a
Dig1Δ Fus3-GFP 1.7 ± 0.17 1.8 ± 0.12 0.3323 <0.0001
Dig2Δ Fus3-GFP 1.6 ± 0.13 1.9 ± 0.16 0.4017 <0.0001
control (Fus3T180AY182A-GFP) 1.6 ± 0.18 2.0 ± 0.14 n/a n/a
dig1Δ Fus3T180AY182A-GFP 1.5 ± 0.16 2.0 ± 0.22 0.2722 0.1771
dig2Δ Fus3T180AY182A-GFP 1.5 ± 0.15 1.9 ± 0.16 0.0744 0.3527
control (empty vector) 1.6 ± 0.19 2.2 ± 0.14 n/a n/a
Msg5 overexpression 1.4 ± 0.13 1.4 ± 0.20 0.0001 <0.0001
Msg5M45A C319A overexpression 1.4 ± 0.12 1.7 ± 0.14 <0.0001 <0.0001
control (NLS-Msg5M45A/NES- 1.7 ± 0.17 1.9 ± 0.20 n/a n/a
Msg5M45A)
NLS-Msg5M45A C319A/NES-Msg5M45A 1.7 ± 0.18 2.1 ± 0.23 0.8380 0.0003
NLS-Msg5M45A/NES-Msg5M45A C319A 1.6 ± 0.18 2.1 ± 0.20 0.0490 0.0003
aRNCF ± s.d. 3 h after pheromone treatment; bρ value when compared to RNCF of untreated control; cρ value when compared to RNCF of 
pheromone-treated control. n = 25 for all experiments. See additional file 1 for histograms used to calculate the RNCF values for Table 1.BMC Cell Biology 2007, 8:44 http://www.biomedcentral.com/1471-2121/8/44
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mulation of Fus3. Conversely, deletion of Msg5 confers
hyper-accumulation of Fus3 in the nucleus [52]. Although
these experiments strongly suggest that Msg5 affects the
localization of Fus3, they do not tell us how. A priori,
Msg5 could mediate its effect on Fus3 by tethering it in the
cytoplasm and/or by dephosphorylating it on either side
of the nuclear membrane. To investigate these possibili-
ties, we first asked where Msg5 itself is located. An Msg5-
GFP reporter was constructed and shown to be functional
by its ability to compliment an msg5Δ allele in pherom-
one-response assays (data not shown). In vegetative cells,
Msg5-GFP appeared to localize uniformly throughout the
cytoplasm and nucleoplasm, and this pattern was
unchanged after pheromone treatment (Fig. 3B). To deter-
mine whether the putative nuclear fluorescence was due
to the presence of Msg5-GFP within the nucleus, and not
simply around it, we compared cells expressing the Msg5
reporter to those expressing Ptp3-GFP. Ptp3 is a tyrosine
phosphatase that inactivates Fus3 and its sister MAPK,
Hog1 [64,65]. The Ptp3-GFP reporter has been shown to
localize exclusively to the cytoplasm [38]. As shown in
Fig. 3A, there is no detectable fluorescence in the nuclei of
cells expressing Ptp3-GFP. This demonstrates that our
imaging system can discern equal nuclear and cytoplas-
mic localization from purely cytoplasmic localization.
Together, these results suggest that Msg5 is distributed
evenly in both compartments, and that its localization
does not change upon pheromone treatment.
Given the apparent distribution of Msg5 throughout the
cytoplasm and the nucleoplasm, the effect of Msg5 on
Fus3 nuclear localization can be explained in either of the
two ways described above: Msg5 might tether Fus3 in the
cytoplasm, just as Ptp3 is thought to tether Hog1 [38].
Alternatively, dephosphorylation of Fus3 by Msg5 might
alter its affinity for anchoring proteins on either side of
the nuclear membrane. Of course, these possibilities are
not mutually exclusive.
To separate the potential abilities of Msg5 to regulate Fus3
by tethering and dephosphorylation, we created a phos-
phatase-dead form of the enzyme, Msg5C319A. The C319A
substitution in Msg5 has been shown to specifically dis-
rupt the catalytic activity of the phosphatase [63]. We then
compared the localization of Fus3-GFP in wild-type cells
and cells overexpressing either Msg5 or Msg5C319A. Excess
Msg5C319A lowered the basal RNCF as effectively as an
excess of wild type Msg5 (Table 1). In contrast, Msg5C319A
was handicapped in its ability to regulate Fus3 localiza-
tion in cells responding to pheromone: Although excess
Msg5C319A lowered the induced RNCF, the pheromone-
stimulated nuclear accumulation of Fus3 was not com-
pletely blocked, as was the case in cells overexpressing
wild-type Msg5 (Table 1). This suggests that the phos-
phatase activity of Msg5 is required for proper regulation
of Fus3 localization during mating.
Does Msg5 inhibit the pheromone-induced change in
RNCF by dephosphorylating Fus3 in the nucleus, the cyto-
plasm, or both? To answer this question, we fused either
the nuclear localization signal (NLS) of the SV40 T anti-
gen [66] or the nuclear export signal (NES) of HIV-1 [67]
to the N-termini of MSG5 and MSG5C319A, preserving the
native  MSG5  promoter sequences. Because the MSG5
message has an alternate translational start site at codon
45 [68], we also engineered M45A substitutions in both
constructs, thereby ensuring that all of the Msg5 protein
encoded by the hybrid genes is N-terminally tagged. The
resulting constructs are designated NLS-MSG5M45A, NES-
MSG5M45A, NLS-MSG5M45AC319A, and NES-MSG5M45A
C319A. All are contained on centromeric (i.e., low-copy)
plasmids.
To determine the efficacy of the NLS and NES tags, we
fused GFP to the C-termini of NLS-MSG5M45A, NES-
MSG5M45A, NLS-MSG5M45AC319A, and NES-MSG5M45A
C319A. Cells transformed with NLS-tagged Msg5 reporters
exhibited dramatic nuclear concentration of the GFP sig-
nal, similar to that seen in cells expressing a GFP-tagged
form of the nuclear phosphatase, Ptp2 (compare Figures
3A and 3C). RNCF measurements indicated that about
80% of the GFP-reporter signal was localized in the nuclei
of cells expressing both NLS-Msg5M45A-GFP and NLS-
MSG5M45AC319A-GFP. Cells transformed with NES-tagged
Msg5 reporters exhibited dramatic cytoplasmic concentra-
tion of the GFP signal, similar to that seen in cells express-
ing a GFP-tagged form of the cytoplasmic phosphatase,
Ptp3 (compare Figures 3A and 3D). RNCF measurements
of the NES-tagged reporters indicated that approximately
70% of the reporter was localized to the cytoplasm.
By transforming an msg5Δ Fus3-GFP strain with various
pairs of the NLS-tagged and NES-tagged Msg5M45A and
Msg5M45AC319A centromeric plasmids, we sought to deter-
mine how Fus3 localization would be affected by loss of
Msg5 phosphatase activity in one compartment or the
other. Three strains were created: the NES-MSG5M45A/
NLS-MSG5M45A cells express enzymatically active Msg5 in
both the cytoplasm and the nucleus; the NES-
MSG5M45AC319A/NLS-MSG5M45A  cells express Msg5 in
both compartments, but little or no phosphatase activity
in the cytoplasm; and the NES-MSG5M45A/NLS-
MSG5M45AC319A cells express Msg5 in both compartments,
with little or no phosphatase activity in the nucleus.
Because all of the MSG5 alleles are expressed from the
native MSG5 promoter, all are carried on low-copy plas-
mids from the YCplac series [69], and all were trans-
formed into the same msg5Δ strain, the level and
partitioning of Msg5 is very unlikely to vary significantlyBMC Cell Biology 2007, 8:44 http://www.biomedcentral.com/1471-2121/8/44
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Localization of the wild type, NLS-tagged, and NES-tagged forms of Msg5 Figure 3
Localization of the wild type, NLS-tagged, and NES-tagged forms of Msg5. A set of 15Dau transformants carrying various cen-
tromeric reporter plasmids–PTP2-GFP, PTP3-GFP, MSG5-GFP, NLS-MSG5M45A-GFP, and NES-MSG5M45A-GFP–were grown to mid-log 
phase, stained with 20 μg/ml DAPI, and examined using fluorescent and differential interference contrast (DIC) microscopy. In each panel, 
representative images are displayed as follows: FITC (left), DAPI (middle), and DIC (right). RNCF values for Msg5-GFP, NLS-MSG5M45A-
GFP, and NES-MSG5M45A-GFP were quantified in the same manner as for Fus3-GFP, and are represented as histograms. RNCF values are 
indicated as the mean ± s.d. (A)PTP2-GFP cells (top); PTP3-GFP cells(bottom); (B)MSG5-GFP cells; (C)NLS-MSG5M45A-GFP cells; (D)NES-
MSG5M45A-GFP cells.BMC Cell Biology 2007, 8:44 http://www.biomedcentral.com/1471-2121/8/44
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amongst the three strains in question. These three strains
should differ only in where Msg5 is enzymatically active.
As shown in Table 1, the basal RNCF values were not sig-
nificantly different in the three strains, suggesting again
that Msg5 phosphatase activity does not play a major role
in regulating the localization of Fus3 in vegetative cells. In
contrast, the pheromone-induced RNCF values were ele-
vated in cells lacking full Msg5 phosphatase activity in
either the cytoplasm or nucleus. This suggests that Msg5
negatively regulates the pheromone response by inactivat-
ing Fus3 both inside and outside of the nucleus.
We have previously established that the relative amount
of Fus3-GFP in the nuclei of pheromone-treated cells cor-
relates with sensitivity to pheromone-induced cell cycle
arrest [52]. To determine whether the deficiency of Msg5
phosphatase activity and the consequent increase in the
induced RNCF also corresponds to heightened sensitivity
to pheromone, we performed halo tests. Compared to our
wild type control strain, the three NES-MSG5/NLS-MSG5
strains all formed smaller halos that were partially filled in
with pheromone resistant colonies (Fig. 4), a phenotype
consistent with overexpression of Msg5 [63]. However,
the three experimental strains were not equally responsive
to pheromone in the halo tests. The cells deficient in cyto-
plasmic Msg5 activity (the NES-MSG5M45AC319A/NLS-
MSG5M45A  cells) were more sensitive to pheromone-
induced growth arrest than the cells with full Msg5 activity
in both compartments (the NES-MSG5M45A/NLS-
MSG5M45A cells), and the cells deficient in nuclear Msg5
activity (the NES-MSG5M45A/NLS-MSG5M45AC319A  cells)
were the most sensitive of all. This suggests that although
Msg5 regulates pheromone-responsiveness in both the
cytoplasm and the nucleus, the nuclear pool of Msg5 has
a greater impact on the cell's sensitivity to pheromone-
induced cell cycle arrest. These observations also
strengthen the correlation between higher RNCF (more
Fus3 in the nucleus) and greater cellular responsiveness to
pheromone.
Discussion
MAPK signaling modules are designed to relay signals
originating at the plasma membrane to nuclear targets.
This is accomplished by the phosphorylation and activa-
tion of the MAPK in the cytoplasm, followed by its accu-
mulation in the nucleus. The signal-induced
redistribution of the MAPK drives the nuclear responses,
whereas these responses attenuate as the level of active
MAPK in the nucleus declines. The kinetics with which
MAPK nuclear activity rises and falls determines both the
degree of response and, in some cases, the type of
response [14-16]. For example, the decision of rat PC12
cells to proliferate or differentiate into neurites is thought
to be controlled by how long Erk remains active in the
nucleus after stimulation [70]. Clearly, the localization of
MAPKs, like their enzymatic activity, must be tightly regu-
lated.
Like Erk1/2, the mating-specific Fus3 MAPK of yeast regu-
lates a developmental switch between proliferation and
differentiation. Pheromone signaling increases the con-
centration of active Fus3 in the nucleus, which causes cell
cycle arrest and induces the morphogenic changes neces-
sary for efficient mating. The results reported by vanDro-
gen et al. [51] suggest that Fus3 diffuses freely into and out
of the nucleus, at a rate unaffected by pheromone. If phe-
romone has no effect on the rate of Fus3 movement, then
how does it increase the level of nuclear Fus3?
Deficient Msg5 phosphatase activity in either the nucleus or  cytoplasm confers increased sensitivity to pheromone Figure 4
Deficient Msg5 phosphatase activity in either the nucleus 
or cytoplasm confers increased sensitivity to pheromone. 
Halo tests were performed as described in [83]. (A)Wildtype 
cells; (B) GAL-MSG5 cells; (C) NES-MSG5M45A/NLS-MSG5M45A 
cells; (D)NES-MSG5M45A/NLS-MSG5M45AC319A; (E) NES-
MSG5M45AC319A/NLS-MSG5M45A cells.BMC Cell Biology 2007, 8:44 http://www.biomedcentral.com/1471-2121/8/44
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Active Fus3 may be tethered by its nuclear substrates
One way to explain the pheromone-induced accumula-
tion of nuclear Fus3 in the absence of regulated transport
is differential tethering: Activation of Fus3 could cause it
to dissociate from cytoplasmic tethers (e.g., Ste5) and
bind to nuclear tethers. Although our experiments do not
directly measure the level of active Fus3 in either compart-
ment, our data are consistent with the idea that Fus3 is
tethered by its nuclear substrates. Dig1 and Dig2 are sub-
strates of Fus3, and each interacts directly with Fus3 in the
nucleus. Deletion of either DIG1  or  DIG2  conferred a
defect in the accumulation of Fus3 in the nuclei of phe-
romone-treated cells but, even though Dig1 and Dig2
bind to the inactive form of Fus3 [46], had no significant
effect on the nucleo-cytoplasmic partitioning of Fus3 in
vegetative cells (Fig. 1). It is unlikely that the aberrant
localization of Fus3 in pheromone-treated cells is due to a
loss of Fus3 function, as dig1Δ and dig2Δ are reported to
have no effect on Fus3 activity [46]. Therefore, the sim-
plest explanation for our results is that Dig1 and Dig2
enhance retention of the phosphorylated/activated form
of Fus3 in the nuclei of mating cells. Alternatively, dele-
tion of DIG1 and DIG2 could affect the ratio of nuclear to
cytoplasmic Fus3 indirectly by altering the expression of
Ste12-regulated genes. Fus3, Msg5, and Dig2 are all
known to be upregulated by Ste12 [71,72].
Another potential nuclear tether for Fus3 is the Ste12 tran-
scription factor. Ste12 is a substrate of Fus3 and the two
proteins directly interact in the nucleus. We found that
overexpression of Ste12 significantly increased the nuclear
accumulation of Fus3 but not of Fus3T180AY182A-GFP in
pheromone-treated cells (Fig. 2), as would be expected if
Ste12 specifically tethers the activated form of Fus3. It has
been reported, however, that pheromone-treatment sub-
stantially diminishes the Fus3-Ste12 association, as
assayed by co-IP [46]. Therefore, we favor the idea that
Ste12 overexpression affects the nuclear accumulation of
Fus3 indirectly, by hyper-inducing the expression of other
nuclear tethers. Dig2 could be one such downstream
tether, as its transcription is induced by pheromone [71].
Indeed, deletion of DIG2 lessened the effect of Ste12 over-
expression on Fus3 localization, although the difference
between the RNCF data sets was not quite statistically sig-
nificant (data not shown). Unfortunately, we were not
able to directly assess the effect of Ste12-induced tran-
scription on Fus3 RNCF because the available transcrip-
tion- alleles of STE12 all contain large deletions, which
could disrupt Ste12-Fus3 interaction. We conclude that
Ste12 contributes to the retention of Fus3 in the nuclei of
mating cells either by direct interaction with activated
Fus3 or, more likely, by inducing the expression of other
Fus3 nuclear anchoring proteins.
The Msg5 phosphatase regulates Fus3 localization
The dual-specific Msg5 phosphatase inactivates Fus3 by
removing the phosphates on residues T180 and Y182. In
earlier work, we reported that overexpression of Msg5 had
a dramatic effect on Fus3 localization: Excess Msg5 low-
ered the relative amount of nuclear Fus3 in vegetative cells
and completely blocked its pheromone-induced nuclear
accumulation [52]. Our discovery that Msg5 localizes
homogenously to both the cytoplasm and the nucleo-
plasm (Fig. 3) is consistent with several means by which
Msg5 might limit the pool of nuclear Fus3. Msg5 could
sequester Fus3 in the cytoplasm, and/or it could dephos-
phorylate Fus3 in either or both compartments. To distin-
guish these possibilities, we examined the effects of
altering Msg5 activity and localization on Fus3-GFP parti-
tioning. We found that overexpression of Msg5C319A, an
enzymatically dead form of the phosphatase, lowered the
basal RNCF as effectively as the overexpressed wild type
enzyme (Table 1). This indicates that Msg5 can sequester
Fus3 in the cytoplasm. However, we do not believe that
Msg5 tethering of Fus3 greatly influences Fus3 localiza-
tion, as the Fus3:Msg5 protein ratio is about 16:1 in vege-
tative cells, and the pheromone-induction of FUS3
transcription is slightly greater than that of MSG5 [73].
A potentially more important finding is shown in Table 1.
As compared to excess wild type Msg5, overexpressed
Msg5C319A was clearly defective in its ability to inhibit the
nuclear accumulation of Fus3 in pheromone-treated cells.
This implies that Msg5 phosphatase activity regulates the
partitioning of Fus3 in mating cells. Given that Msg5 is
overexpressed from the strong GAL1 promoter in these
experiments, however, the extent to which dephosphor-
ylation of Fus3 by Msg5 affects the localization of the
kinase under physiological conditions was unclear. We
were also interested to know whether Fus3 inactivation
could be specifically attributed to the nuclear Msg5 phos-
phatase activity, as the cytoplasmic and nuclear pools of
Msg5 could play distinct roles in Fus3 regulation. To
address these questions, we constructed a set of three
strains designed to express the same total amount of Msg5
in each compartment, but which are distinguished by
whether they express Msg5 phosphatase activity in the
cytoplasm, the nucleus, or both. Although Msg5 appears
to be at least slightly overexpressed in these strains, as
indicated by the halo tests (Fig. 4), the Msg5 levels are pre-
sumed to be more nearly normal than in the cells express-
ing MSG5 from the GAL1 promoter (compare the halo
formed by the GAL1-MSG5 cells to the halos formed by
the other strains). In essence, these strains allow us to ask
what happens to the localization of Fus3 when Msg5
phosphatase activity is specifically turned off in either the
nucleus or cytoplasm, while holding the total amount of
Msg5 constant. Our data indicate that Fus3 hyper-local-
izes to the nuclei of pheromone-treated cells lacking Msg5BMC Cell Biology 2007, 8:44 http://www.biomedcentral.com/1471-2121/8/44
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phosphatase activity in either compartment (Table 1). In
contrast, loss of Msg5 phosphatase activity had no effect
on the partitioning of Fus3 in vegetative cells (Table 1).
These results strongly suggest that dephosphorylation/
inactivation of Fus3 is an important means of regulating
its localization in cells responding to pheromone, and
that Msg5 performs this function in both the nucleus and
cytoplasm.
Consistent with our previous results [52], the hyper-accu-
mulation of Fus3 in the nuclei of Msg5 phosphatase-defi-
cient cells correlated with increased sensitivity to
pheromone-induced cell cycle arrest: The halos formed by
cells lacking Msg5 phosphatase activity in the nucleus or
cytoplasm were larger and less filled than those formed by
the control cells (Fig. 4). Interestingly, loss of nuclear
Msg5 phosphatase activity conferred a slightly more sen-
sitive halo phenotype than loss of Msg5 phosphatase
activity in the cytoplasm, suggesting that nuclear Msg5 has
a greater impact on Fus3 regulation of the cell cycle than
the cytoplasmic pool of the phosphatase.
A limitation of these Msg5-partitioning experiments is
that we did not directly measure the nuclear and cytoplas-
mic levels of the various Msg5 forms. Although such
measurements could strengthen our conclusions in prin-
ciple, immunoblot-quantification of Msg5 after cell frac-
tionation would not be sufficiently precise to be
meaningfully correlated with the RNCF differentials that
we observed. A priori, it is possible that the M45A or
C319A substitutions in Msg5 could decrease its half-life.
However, Flandez et al. have shown that myc-tagged
Msg5M45A is no less stable than the myc-tagged wild type
protein [68], and the results of our Fus3-GFP localization
assays argue strongly against the possibility that the
C319A mutation destabilizes Msg5. As shown in Table 1,
overexpression of Msg5M45AC319A  has the exact same
impact on the basal RNCF as does the overexpression of
Msg5, and expression of NES-Msg5M45AC319A instead of
NES-Msg5M45A had no effect on the basal RNCFs. (If the
C319A substitution conferred a significant decrease in the
steady-state level of cytoplasmic Msg5, we would expect
the basal RNCF values to increase, as is the case in msg5Δ
cells [52]). Finally, even if we suppose that the steady-state
level of NLS-Msg5M45AC319A is lower than that of NLS-
Msg5M45A, we would expect to find this difference in all
the strains analyzed for Fig. 4 and the bottom section of
Table 1. Instead of concluding that the Msg5 phosphatase
activity in both the cytoplasm and nucleus inhibits phe-
romone-induced Fus3 nuclear localization, we would
conclude simply that both cytoplasmic and nuclear Msg5
inhibits pheromone-induced Fus3 nuclear localization.
Nucleo-cytoplasmic partitioning of Fus3–a switch and a 
timer
Considering our results with those of others, pheromone-
induced nuclear accumulation can be explained quite
simply as follows: Fus3 diffuses freely into and out of the
nucleus at a rate that is unaffected by pheromone [51].
When the cell is exposed to pheromone, Fus3 is phospho-
rylated by Ste7, which causes it to shift to its active confor-
mation. Activation of the kinase triggers its dissociation
from Ste5 [53], while increasing its affinity for its nuclear
targets. The interaction of Fus3 with its nuclear targets
then retards its diffusion out of the nucleus. In short, Fus3
accumulates in the nucleus of pheromone-treated cells as
the result of signal-induced changes in cytoplasmic and
nuclear tethering. Fus3/Ste12-induced transcription of
nuclear tethers (e.g., Dig2) would be expected to further
increase the retention of Fus3 in the nucleus, thus creating
a positive feedback loop. The fact that the absence of Dig1
or Dig2 did not affect the basal RNCF or completely
inhibit the pheromone-induced increase in the RNCF sug-
gests that there are other proteins involved in the nuclear
tethering of Fus3.
Our results also suggest that Msg5 antagonizes the nuclear
localization of Fus3. By removing the activating phos-
phates on Fus3, Msg5 decreases its affinity for its nuclear
tethers. In addition to promoting adaptation to pherom-
one and return to the ground-state partitioning of Fus3
after cell fusion, this mechanism may play an important
role in regulating the mating response. Looking at the sys-
tem as a whole, the primary job of the MAPK is to report
the status of the membrane-bound receptor to the
nucleus. As long as Fus3 remains active, the cell is insensi-
tive to changes in receptor signaling. Msg5 limits the dura-
tion of Fus3 activity, thereby ensuring that the kinase
periodically re-associates with the Ste5 scaffold, where it
receives updates about the upstream elements in the path-
way. Thus, Msg5 is a timer. By continually reversing the
Fus3 activation switch (phosphorylation), Msg5 sharpens
the temporal connection between the stimulus and
response.
If the nuclear accumulation of Fus3 is due to pheromone-
induced tethering, as we suggest, then the flux of Fus3
from the nucleus to cytoplasm of cells responding to phe-
romone should decrease. Why was this change undetected
when vanDrogen et al. tried to measure it? Most likely, the
decrease in Fus3 "export" due to induced nuclear tether-
ing is too small to be observed by FRAP analysis. The error
in their measurement (~9%) is much greater than the rate
change in Fus3 movement out of the nucleus that we
would expect to see, assuming the nuclear accumulation
of Fus3 is linear over time.BMC Cell Biology 2007, 8:44 http://www.biomedcentral.com/1471-2121/8/44
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Another prediction of our model is that a mutant form of
Fus3 that cannot be phosphorylated should be unable to
accumulate in the nuclei of pheromone-treated cells.
Indeed, the induced RNCF of the Fus3T180AY182A-GFP
reporter is significantly lower than normal (Table 1). On
the other hand, pheromone treatment of wild type cells
expressing Fus3T180AY182A-GFP does induce some increase
in RNCF. If the phosphorylation of Fus3 is essential to its
nuclear tethering, then why does the Fus3T180AY182A-GFP
reporter accumulate in the nuclei of pheromone-treated
cells at all? One possibility is that Fus3T180AY182A-GFP
dimerizes with wild type Fus3, and these heterodimers are
retained in the nucleus by a subset of Fus3 targets. In sup-
port of this explanation, Fus3 interacts with itself in the
two-hybrid assay [74], and the Erk MAPKs are known to
dimerize in response to stimulus [75]. Although we have
not tested Fus3 dimerization directly, one of our previ-
ously published observations is consistent with it: Phe-
romone induces the nuclear accumulation of the
Fus3T180AY182A-GFP reporter in cells expressing either Fus3
or Kss1 (which also interacts with Fus3 in the two-hybrid
assay), but not in cells lacking functional copies of both
these MAPKs [52]. Alternatively, the phosphorylation of
Fus3 may be necessary for its efficient tethering by some
nuclear proteins (e.g., Dig1 and Dig2), but not others. In
this view, the pheromone-induced nuclear accumulation
of Fus3T180AY182A-GFP would require expression of func-
tional Fus3 or Kss1 because tethering is augmented by the
MAPK-dependent phosphorylation of some Fus3 anchor-
ing proteins.
Conclusion
Our findings suggest that phosphorylation of Fus3 aug-
ments its ability to interact with nuclear tethers, which
explains the nuclear accumulation of Fus3 observed after
pheromone pathway activation. Additionally, the Msg5
phosphatase counteracts the nuclear accumulation of
Fus3 by dephosphorylating it in both the nucleus and the
cytoplasm. The continual dephosphorylation of Fus3
throughout the cell may enhance the temporal sensitivity
of the pheromone pathway, thereby promoting a rapid
adjustment of signalling intensity in response to changes
in the pheromone gradient.
Methods
Molecular and microbiological techniques
Recombinant DNA techniques were essentially as
described by Sambrook et al. [76] and by Ausubel et al.
[77].
Yeast transformations were carried out according to the
method of Ito et al. [78]. Yeast growth media were pre-
pared as described by Sherman et al. [79]. Amino acids
were omitted as necessary to select for plasmids. For
experiments requiring the induction of the GAL1-regu-
lated genes, cells were either grown to mid-log phase in
sucrose medium and galactose added to a final concentra-
tion of 2%, or the cells were cultured overnight in
medium containing galactose. The yeast strains used in
this study are listed in Table 2.
Plasmids and strains
All strains used in the present study were derived from
strain 15Dau (MATa  bar1Δ  ade1 his2 leu2–3,112 trp1
ura3Δ), which is isogenic with strain BF264-15D [80].
Deletion mutations were created by transformation with
disruption plasmids and PCR products containing the
yeast markers URA3 and LEU2 and the bacterial markers
KanMx and HISG (Table 3). KanMx deletion cassettes
were also amplified from the yeast deletion library [81].
Disruptions were confirmed by genomic PCR analysis and
by pheromone response assays.
The plasmids used in this study are listed in Table 3. The
construction of those that were created for this investiga-
tion is described below. All mutations were introduced
using the QuikChange site-directed mutagenesis kit
(Stratagene, La Jolla, CA), and all mutagenized products
were sequenced by either Macrogen (Seoul, Korea) or
Functional Biosciences, Inc. (Madison, WI).
(i) GAL-MSG5C319A (TBB109)
The phosphatase dead version of Msg5 was created using
the GAL1-MSG5 plasmid HKB100 [52] as a template. The
primers used to introduce the C319A mutation were 5'-
CTCGTACACGCTCAGTGTGG AGTATCAAGA TCGG-3'
and 5'-CCGATCTTGA TACTCCACAC TGAGCGTGTA
CGAG-3'. The substitutions are underlined.
Table 2: S. cerevisiae strains used in this study
Strain Relevant genotype Source
15Dau MATa bar1Δ ade1 his2 leu2–3,112 trp1 ura3Δ [80]
IHY165 MATa bar1Δ ade1 his2 leu2–3,112 trp1 ura3Δ fus3Δ::LEU2 kss1Δ::KanMx This study
TBY281 MATa bar1Δ ade1 his2 leu2–3,112 trp1 ura3Δ fus3Δ::LEU2 dig1Δ::KanMx This study
TBY287 MATa bar1Δ ade1 his2 leu2–3,112 trp1 ura3Δ fus3Δ::LEU2 dig2Δ::KanMx This study
HKY137 MATa bar1Δ ade1 his2 leu2–3,112 trp1 ura3Δ msg5Δ::LEU2 This studyBMC Cell Biology 2007, 8:44 http://www.biomedcentral.com/1471-2121/8/44
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(ii) GAL1-STE12 (TBB157)
The 0.680 kb BamHI-EcoRI fragment containing the diver-
gent GAL1/GAL10 promoter was moved from YCpG2 [82]
to the polylinker of YCplac22 [69] to create plasmid
ZWB159. The STE12  coding region (-20 to 2200) was
amplified from genomic DNA by using the following
primers: 5'-TGACCAAGCTTGAATTGTCT TGTTCACCAA
GG-3', which contains a HindIII site (underlined), and 5'-
AAACTGCAGG CTCTAGTCTT GTATAAGATT G-3', which
contains a PstI site (underlined). The STE12 PCR product
was then digested with HindIII and PstI, and ligated into
HindIII-PstI-cut ZWB159 to create the GAL1-STE12 tran-
scriptional fusion vector.
(iii) NLS-MSG5M45A (TBB172, TBB181) and NES-MSG5M45A 
(TBB174, TBB180)
The MSG5 coding region and promoter (-381 to 1470)
were amplified from genomic DNA using the following
primers: 5'-CCAACTGCAG ATGGTCCATC CTGGTAAG-
3', which contains a PstI  site (underlined), and 5'-
GCGCGGATCC TTAAGGAAGA AACATCATCT GTT-3',
which contains a BamHI  site (underlined). The MSG5
PCR product was then digested with PstI and BamHI, and
ligated into PstI-BamHI-cut YCplac22 [69]. To introduce
the M45A mutation, the resulting MSG5/YCplac22 plas-
mid was amplified using the following primers: 5'-
GGCTTGGCGA TGAGAATTCC GCTAATGGAT GGAGT-
GCTGC-3' and 5'-GCAGCACTCC ATCCATTAGC GGAAT-
TCTCA TCGCCAAGCC-3'. The mutations are underlined.
The resulting MSG5M45A plasmid was then used as a tem-
plate in two mutagenic PCR reactions designed to insert
either the NLS sequence [66] or the NES sequence [67]
immediately after the MSG5 start codon. The NLS tag was
added using the following primers: 5'-GGTAGCGATA
AGTGCACATG CCGAAGAAGAAGCGCAAGGTGCAATT-
TCAC TCAGATAAGC AGC-3' and 5'-GCTGCTTATC
TGAGTGAAAT TGCACCTTGCGCTTCTTCTTCGGCAT-
GTGC ACTTATCGCT ACC-3'. The NLS region is under-
lined. The NES tag was added using the following primers:
5'-GGTAGCGATA AGTGCACATG CTCCAGCTCCCAC-
CACTCGAGCGACTCACACTCCAATTTC ACTCAGATAA
GCAGC-3' and 5'-GCTGCTTATC TGAGTGAAAT
TGGAGTGTGAGTCGCTCGAGTGGTGGGAGCTGGAG-
CATGT GCACTTATCG CTACC-3'. The NES region is
underlined. The resulting plasmids, YCplac22 NLS-
MSG5M45A and YCplac22 NES-MSG5M45A (TBB172 and
TBB174), were digested with BamHI and PstI. The NLS-
MSG5M45A and NES-MSG5M45A fragments were then puri-
fied and ligated into PstI-BamHI-cut YCplac33 to generate
the desired YCplac33 NLS-MSG5M45A and YCplac33 NES-
MSG5M45A plasmids (TBB181 and TBB180).
(iv) NLS-MSG5M45A C319A (TBB178) and NES-MSG5M45A C319A 
(TBB176)
To generate the C319A mutation in MSG5, plasmids
TBB172 and TBB174 were used as templates. The muta-
genic primers were: 5'-CTCGTACACGCTCAGTGTGG
AGTATCAAGA TCGG-3' and 5'-CCGATCTTGA TACTC-
CACAC TGAGCGTGTA CGAG-3'. The substitutions are
underlined.
(v) NLS-MSG5M45A-GFP (TBB171) and NES-MSG5M45A-GFP 
(TBB170)
The MSG5-GFP plasmid, HKY 101 [52], was used as a
template for two PCR reactions designed to insert either
the NLS sequence [66] or the NES sequence [67] immedi-
Table 3: Plasmids used in this study
Plasmid Marker Source
pIH4.1 URA3 CEN FUS3-GFP [52]
pIH4.1AA URA3 CEN FUS3T180AY182A-GFP [52]
YCplac22/FUS3-GFP (AOB117) TRP1 CEN FUS3-GFP [52]
YCplac22/FUS3T180AY182A-GFP (TBB182) TRP1 CEN FUS3T180AY182A-GFP [52]
pRS316CG/MSG5-GFP (HKB101) URA3 CEN MSG5-GFP [52]
YCplac111/GAL1-MSG5 (HKB100) LEU2 CEN GAL1-MSG5 [52]
YCplac22/GAL1-MSG5 (AEB101) TRP1 CEN GAL1-MSG5 [52]
YCplac111/GAL1-MSG5C319A (TBB109) LEU2 CEN GAL1-MSG5C319A This study
YCplac22/GAL1-STE12 (TBB157) TRP1 CEN GAL1-STE12 This study
YCplac22/NLS-MSG5M45A (TBB172) TRP1 CEN NLS-MSG5M45A This study
YCplac22/NES-MSG5M45A (TBB174) TRP1 CEN NES-MSG5M45A This study
YCplac33/NLS-MSG5M45A (TBB181) URA3 CEN NLS-MSG5M45A This study
YCplac33/NES-MSG5M45A (TBB180) URA3 CEN NES-MSG5M45A This study
YCplac22/NLS-MSG5M45AC319A (TBB178) TRP1 CEN NLS-MSG5M45AC319A This study
YCplac22/NES-MSG5M45AC319A (TBB176) TRP1 CEN NES-MSG5M45AC319A This study
pRS316CG/NLS-MSG5-GFPM45A (TBB171) URA3 CEN NLS-MSG5M45A-GFP This study
pRS316CG/NES-MSG5-GFPM45A (TBB170) URA3 CEN NES-MSG5M45A-GFP This study
YEplac181/PTP2-GFP LEU2 2 μ PTP2-GFP [84]
YEplac181/PTP3-GFP LEU2 2 μ PTP3-GFP [84]BMC Cell Biology 2007, 8:44 http://www.biomedcentral.com/1471-2121/8/44
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ately after the start codon of MSG5. The NLS was added
using the following primers: 5'-GGTAGCGATA AGTGCA-
CATG CCGAAGAAGAAGCGCAAGGTGCAATTTCAC
TCAGATAAGC AGC-3' and 5'-CCATCGCTAT TCACGTG-
TAC GGCTTCTTCTTCGCGTTCCACGTTAAAGTG AGTC-
TATTCG TCG-3'. The NLS region is underlined. The NES
was added using the following primers: 5'-GGTAGCGATA
AGTGCACATG CTCCAGCTCCCACCACTCGAGCGACT-
CACACTCCAATTTC ACTCAGATAA GCAGC-3' and 5'-
CCATCGCTAT TCACGTGTAC GAGGTCGAGGGTGGT-
GAGCTCGCTGAGTGTGAGGTTAAAG TGAGTCTATT
CGTCG-3'. The NES region is underlined. Following iso-
lation of the NLS-MSG5-GFP and NES-MSG5-GFP con-
structs, a 985 bp ClaI-NsiI fragment of MSG5 (46–1031
bp), was replaced in each with the corresponding frag-
ment from TBB172, which contains the M45A mutation.
The resulting plasmids were designated NLS-MSG5M45A-
GFP and NES-MSG5M45A-GFP.
(vi) YCplac22/Fus3T180A Y182A-GFP (TBB182)
The  EcoRI-SacI  fragment containing the Fus3T180AY182A-
GFP translational fusion was moved from IH4.1AA [52]
to YCplac22 [69].
Pheromone response halo tests
Strains were tested for pheromone-induced growth inhi-
bition in standard halo assays as previously described
[83].
Photomicrographs and quantification of Fus3-GFP 
localization
Fluorescent and differential interference contrast (DIC)
images were acquired using a Zeiss Axioskop 2 micro-
scope fitted with a Zeiss AxioCam digital camera, and
processed using Zeiss AxioVision software. Localization of
Fus3-GFP was performed as described in [52]. Briefly, the
Fus3-GFP signal was quantified from digital images by
using the histogram function of Adobe Photoshop 5.5. A
circle of set size was used to sample the brightness of the
nucleus and cytoplasm of cells from randomly chosen
fields. The ratio of nuclear to cytoplasmic fluorescence
was rounded to the nearest 0.1, and values corresponding
to at least 25 cells for each strain and condition were plot-
ted in histograms. All such experiments were performed at
least three times and individual experiments illustrating
the general trend seen throughout all experiments are pre-
sented. Student's t-test was used for statistical analysis.
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Additional file 1
RNCF calculations for strains listed in Table 1. Description: Strains of the 
indicated genotype were transformed with Fus3-GFP (A and E-I) or 
Fus3T180AY182A-GFP (B-D) and grown to mid-log phase. The cultures 
were then split and grown with or without the addition of 12 nM pherom-
one. Images were acquired from the treated and untreated cells three 
hours later. The RNCF values were determined as described in the Mate-
rials and Methods, and their distributions represented in histograms. The 
number of cells (y axis) is plotted as a function of the RNCF values (x 
axis). Mean RNCF values are indicated ± s.d. In each panel, the 
untreated and treated cultures are represented by the left and right histo-
grams, respectively. Arrows indicate the mean RNCF value for each cul-
ture. (A)Wild type cells with Fus3-GFP; (B) Wild type cells with 
Fus3T180AY182A-GFP; (C) dig1Δ cells; (D)dig2Δ cells; (E) Msg5 overex-
pression cells; (F) MSG5M45AC319A overexpression cells; (G) NES-
MSG5M45A/NLS-MSG5M45A cells; (H) NES-MSG5M45A/NLS-
MSG5M45AC319A cells; (I) NES-MSG5M45AC319A/NLS-MSG5M45A cells.
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[http://www.biomedcentral.com/content/supplementary/1471-
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Additional file 2
Ste12 overexpression causes hyper-accumulation of Fus3 in the nuclei of 
pheromone-treated cells. Wild type cells were transformed with either the 
Fus3-GFP reporter or the Fus3T180AY182A-GFP reporter, and either the 
GAL1-STE12 plasmid or an empty vector. Strains were grown to mid-log 
phase in sucrose medium and galactose was added to a concentration of 
2% two hours before pheromone treatment (GAL1 promoter on). The cul-
tures were then split and grown with or without the addition of 12 nM 
pheromone. Images were acquired from the untreated and treated cultures 
in 2 hour intervals. The 2 hr, 4 hr, and 6 hr time points indicate time 
elapsed after galactose induction. (A) untreated wild type cells expressing 
Fus3-GFP; (B) pheromone-treated wild type cells expressing Fus3-GFP; 
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